This episode allows us to take a glimpse at how cancer risk screening and pharmacogenomics (PGx) testing at scale, as a standard patient experience supported by workflow tools and system champions, can catch cancer sooner and make treatments safer, while cutting health care costs.
Burns Blaxall explains how he led implementation of a precision medicine program at The Christ Hospital in Cincinnati, OH that combined cancer-risk screening and PGx across thousands of patients. In tracking the financial impact of optimized drug prescribing and avoiding adverse drug events, this program revealed a dramatic cost savings of about $7000 per patient!
You’ll find these takeaways super enlightening!
- Early cancer detection and targeted prescribing save lives!
- Incorporating genetics into The Christ Hospital ecosystem cut downstream costs of care. True measurable and published ROI.
- Precision medicine implementation is feasible but needs infrastructure. Success requires workflow integration, decision-support tools, clinician training, and data-driven ROI tracking to move from pilot to sustainable program.
